Product Description: BNT411 is a selective TLR7 agonist that can induce the release of IFNa both in vivo and in vitro. BNT411 has anticancer activity and can be used in cancer research, including non-small cell lung cancer, pancreatic cancer, and untreated extensive-stage small cell lung cancer (ES-SCLC)[1].
Formula: C24H33N5O3
References: [1]Ugur Sahin, et al. Tlr7 agonist and combinations for cancer treatment. WIPO. WO2023083868. 2023-05-19
CAS Number: 2296821-50-4
Molecular Weight: 439.55
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Toll-like Receptor (TLR)